HK1165280A1 - 芐達明在治療 依賴性疾病中的用途 - Google Patents

芐達明在治療 依賴性疾病中的用途

Info

Publication number
HK1165280A1
HK1165280A1 HK12105915.7A HK12105915A HK1165280A1 HK 1165280 A1 HK1165280 A1 HK 1165280A1 HK 12105915 A HK12105915 A HK 12105915A HK 1165280 A1 HK1165280 A1 HK 1165280A1
Authority
HK
Hong Kong
Prior art keywords
benzydamine
treatment
dependent diseases
diseases
dependent
Prior art date
Application number
HK12105915.7A
Other languages
English (en)
Inventor
Angelo Guglielmotti
Giorgina Mangano
Giuseppe Biondi
Original Assignee
Aziende Chimiche Riunite Angelini Francesco A C R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco A C R filed Critical Aziende Chimiche Riunite Angelini Francesco A C R
Publication of HK1165280A1 publication Critical patent/HK1165280A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
HK12105915.7A 2009-07-08 2012-06-18 芐達明在治療 依賴性疾病中的用途 HK1165280A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09425270 2009-07-08
PCT/EP2010/058881 WO2011003737A1 (en) 2009-07-08 2010-06-23 USE OF BENZYDAMINE IN THE TREATMENT OF p40-DEPENDENT DISEASES

Publications (1)

Publication Number Publication Date
HK1165280A1 true HK1165280A1 (zh) 2012-11-23

Family

ID=41279454

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12105915.7A HK1165280A1 (zh) 2009-07-08 2012-06-18 芐達明在治療 依賴性疾病中的用途

Country Status (26)

Country Link
US (1) US20120302618A1 (zh)
EP (1) EP2451452B1 (zh)
JP (1) JP5753843B2 (zh)
KR (1) KR101723996B1 (zh)
CN (1) CN102470125B (zh)
AR (1) AR077451A1 (zh)
AU (1) AU2010270425B2 (zh)
BR (1) BR112012000410B8 (zh)
CA (1) CA2760176C (zh)
CY (1) CY1116914T1 (zh)
DK (1) DK2451452T3 (zh)
EA (1) EA022862B1 (zh)
ES (1) ES2554332T3 (zh)
GE (1) GEP20146156B (zh)
HK (1) HK1165280A1 (zh)
HR (1) HRP20151393T8 (zh)
HU (1) HUE028220T2 (zh)
IL (1) IL216717A (zh)
MX (1) MX2012000498A (zh)
PL (1) PL2451452T3 (zh)
PT (1) PT2451452E (zh)
SG (2) SG176686A1 (zh)
SI (1) SI2451452T1 (zh)
SM (1) SMT201500277B (zh)
UA (1) UA105666C2 (zh)
WO (1) WO2011003737A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201706369PA (en) * 2015-02-09 2017-09-28 Cellix Bio Private Ltd Compositions and methods for the treatment of mucositis
US20180244792A1 (en) * 2015-09-10 2018-08-30 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Anti-fibrotic effect of cd70
CN109562058A (zh) * 2016-07-08 2019-04-02 方济各安吉利克化学联合股份有限公司 包含苄达明的药物组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054833A (zh) 1963-08-09
IT1184123B (it) 1985-01-22 1987-10-22 Acraf Impiego della benzidamina nel trattamento delle infezioni da trichomonas vaginalis e gardnerella vaginalis
IT1276040B1 (it) * 1993-07-27 1997-10-24 Angelini Francesco Ist Ricerca Uso della benzidamina nel trattamento di stati patologici causati dal tnf
IT1274026B (it) 1994-03-01 1997-07-14 Acraf Composizione antitosse
IT1274655B (it) * 1995-02-28 1997-07-18 Smithkline Beecham Farma Composizioni farmaceutiche contenenti un agente antiinfiammatorio e un agente antimicrobico
CA2594718C (en) * 2005-01-14 2012-01-24 Camurus Ab Gnrh analogue formulations
DK1845942T3 (da) * 2005-01-14 2014-04-28 Camurus Ab GNRH-analogformuleringer
GB0604824D0 (en) * 2006-03-09 2006-04-19 Arakis Ltd The treatment of inflammatory disorders

Also Published As

Publication number Publication date
SMT201500277B (it) 2016-01-08
ES2554332T3 (es) 2015-12-18
WO2011003737A1 (en) 2011-01-13
SG10201403088XA (en) 2014-10-30
GEP20146156B (en) 2014-09-10
HRP20151393T1 (hr) 2016-01-15
SI2451452T1 (sl) 2015-12-31
KR101723996B1 (ko) 2017-04-06
AU2010270425A1 (en) 2011-12-22
KR20120052201A (ko) 2012-05-23
CN102470125A (zh) 2012-05-23
HUE028220T2 (en) 2016-12-28
HRP20151393T8 (hr) 2016-07-01
JP2012532173A (ja) 2012-12-13
EP2451452B1 (en) 2015-10-07
UA105666C2 (uk) 2014-06-10
CN102470125B (zh) 2015-08-19
BR112012000410B8 (pt) 2020-12-08
JP5753843B2 (ja) 2015-07-22
SG176686A1 (en) 2012-01-30
CA2760176C (en) 2017-01-03
AR077451A1 (es) 2011-08-31
IL216717A (en) 2017-06-29
AU2010270425B2 (en) 2016-07-28
MX2012000498A (es) 2012-04-30
CA2760176A1 (en) 2011-01-13
BR112012000410A2 (pt) 2016-04-05
EP2451452A1 (en) 2012-05-16
IL216717A0 (en) 2012-02-29
EA201270143A1 (ru) 2012-06-29
BR112012000410B1 (pt) 2019-12-31
DK2451452T3 (en) 2015-11-23
CY1116914T1 (el) 2017-04-05
US20120302618A1 (en) 2012-11-29
EA022862B1 (ru) 2016-03-31
PL2451452T3 (pl) 2016-03-31
PT2451452E (pt) 2016-01-14

Similar Documents

Publication Publication Date Title
HK1211889A1 (zh) 二氨基吩噻嗪的治療用途
HK1153926A1 (zh) 用於治療 -相關疾病的嘌呤衍生物
ZA201202384B (en) Jak2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer
GB0803018D0 (en) Therapeutic compounds and their use
GB0804685D0 (en) Therapeutic compounds and their use
GB0807609D0 (en) Therapeutic compounds and their use
ZA201201287B (en) Therapeutic aryl-amido-aryl compounds and their use
HK1171677A1 (zh) 用於治療痔及相關疾病的組合物
GB0817208D0 (en) Therapeutic apsap compounds and their use
IL213703A (en) Compounds for the treatment of pain and other diseases
GB0822486D0 (en) Compounds for use in the treatment of pain
HUE031337T2 (hu) Opioidok rezisztens rákos betegek kezelésében történõ alkalmazásra
HRP20151393T8 (hr) UPORABA BENZIDAMINA U LIJEČENJU BOLESTI KOJE SU p40-OVISNE
GB0812913D0 (en) Therapeutic compounds and their use
GB0710277D0 (en) Use of antivirals in the treatment of medical disorders
HK1214771A1 (zh) 用於治療皮膚病的製劑
PL2265279T3 (pl) Zastosowanie nonapeptydu pat w leczeniu chorób autoimmunologicznych
GB0802128D0 (en) Therapeutic compounds and their use
GB0814043D0 (en) The treatment of skin disorders
GB0815134D0 (en) Therapeutic compounds and their use
HUP1000688A2 (en) Use of trifluoro-phthalimides in the treatment of cancer
GB0801511D0 (en) The treatment of ophthalmic diseases
GB0913300D0 (en) Therapeutic compounds and their use
GB0821539D0 (en) Therapeutic compounds and their use
GB0819854D0 (en) Therapeutic use of zolpidem

Legal Events

Date Code Title Description
AM Amended specification (according sect 146 of patent law)

Free format text: CORRECTION OF THE NAME OF APPLICANT FROM AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R. TO AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A.

Effective date: 20170420

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220623